nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.0597	0.0623	CcSEcCtD
Enzalutamide—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0479	0.0501	CcSEcCtD
Enzalutamide—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.0373	0.039	CcSEcCtD
Enzalutamide—Injury—Riluzole—amyotrophic lateral sclerosis	0.034	0.0355	CcSEcCtD
Enzalutamide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0332	0.0347	CcSEcCtD
Enzalutamide—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.0275	0.0288	CcSEcCtD
Enzalutamide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0259	0.0271	CcSEcCtD
Enzalutamide—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0252	0.0264	CcSEcCtD
Enzalutamide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0249	0.026	CcSEcCtD
Enzalutamide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.0242	0.0253	CcSEcCtD
Enzalutamide—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0241	0.0251	CcSEcCtD
Enzalutamide—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0241	0.0251	CcSEcCtD
Enzalutamide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0229	0.024	CcSEcCtD
Enzalutamide—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0227	0.0237	CcSEcCtD
Enzalutamide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0226	0.0236	CcSEcCtD
Enzalutamide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0216	0.0226	CcSEcCtD
Enzalutamide—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0215	0.0225	CcSEcCtD
Enzalutamide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0214	0.0224	CcSEcCtD
Enzalutamide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0213	0.0223	CcSEcCtD
Enzalutamide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0213	0.0222	CcSEcCtD
Enzalutamide—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0212	0.0222	CcSEcCtD
Enzalutamide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0212	0.0221	CcSEcCtD
Enzalutamide—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0196	0.0205	CcSEcCtD
Enzalutamide—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0189	0.0198	CcSEcCtD
Enzalutamide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0182	0.019	CcSEcCtD
Enzalutamide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0176	CcSEcCtD
Enzalutamide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0176	CcSEcCtD
Enzalutamide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0163	0.017	CcSEcCtD
Enzalutamide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0162	0.017	CcSEcCtD
Enzalutamide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.016	0.0167	CcSEcCtD
Enzalutamide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0167	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0166	CcSEcCtD
Enzalutamide—Infection—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0159	CcSEcCtD
Enzalutamide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.015	0.0157	CcSEcCtD
Enzalutamide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.015	0.0157	CcSEcCtD
Enzalutamide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0156	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.014	0.0146	CcSEcCtD
Enzalutamide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0145	CcSEcCtD
Enzalutamide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0144	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0138	CcSEcCtD
Enzalutamide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0138	CcSEcCtD
Enzalutamide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.011	0.0115	CcSEcCtD
Enzalutamide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0113	CcSEcCtD
Enzalutamide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0105	0.011	CcSEcCtD
Enzalutamide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0106	CcSEcCtD
Enzalutamide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00961	0.01	CcSEcCtD
Enzalutamide—AR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000205	0.00476	CbGpPWpGaD
Enzalutamide—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000196	0.00456	CbGpPWpGaD
Enzalutamide—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000195	0.00454	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000194	0.0045	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000193	0.00449	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000186	0.00433	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000184	0.00427	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000183	0.00426	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000182	0.00424	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.00018	0.00419	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000178	0.00414	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000177	0.00411	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000175	0.00408	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—amyotrophic lateral sclerosis	0.000174	0.00405	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000174	0.00404	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000169	0.00393	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000167	0.00389	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000167	0.00389	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000166	0.00386	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000153	0.00355	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000152	0.00353	CbGpPWpGaD
Enzalutamide—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000152	0.00353	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000149	0.00347	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000145	0.00337	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000142	0.0033	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000142	0.0033	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000141	0.00329	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000138	0.00322	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000136	0.00317	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000136	0.00316	CbGpPWpGaD
Enzalutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000135	0.00314	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000134	0.00311	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000133	0.00309	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000132	0.00307	CbGpPWpGaD
Enzalutamide—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000129	0.003	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000128	0.00298	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000128	0.00297	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000127	0.00295	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000126	0.00293	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000124	0.00289	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000122	0.00284	CbGpPWpGaD
Enzalutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000121	0.00281	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00012	0.00278	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000119	0.00277	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000119	0.00277	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000116	0.00271	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000116	0.00269	CbGpPWpGaD
Enzalutamide—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000115	0.00268	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000115	0.00267	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000115	0.00267	CbGpPWpGaD
Enzalutamide—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000113	0.00263	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000112	0.00261	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000111	0.00259	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000111	0.00258	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000111	0.00257	CbGpPWpGaD
Enzalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00011	0.00256	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000109	0.00253	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000108	0.00251	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000107	0.0025	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000106	0.00247	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000105	0.00244	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	9.89e-05	0.0023	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.71e-05	0.00226	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	9.58e-05	0.00223	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.58e-05	0.00223	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	9.4e-05	0.00219	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9.18e-05	0.00214	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	9.16e-05	0.00213	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.15e-05	0.00213	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.1e-05	0.00212	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	8.91e-05	0.00207	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	8.88e-05	0.00207	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	8.79e-05	0.00204	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	8.79e-05	0.00204	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.67e-05	0.00202	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	8.63e-05	0.00201	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	8.59e-05	0.002	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	8.59e-05	0.002	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	8.55e-05	0.00199	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.55e-05	0.00199	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.17e-05	0.0019	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	8.09e-05	0.00188	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	8.04e-05	0.00187	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.97e-05	0.00185	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.9e-05	0.00184	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.86e-05	0.00183	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	7.86e-05	0.00183	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.79e-05	0.00181	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.79e-05	0.00181	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.71e-05	0.00179	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	7.58e-05	0.00176	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	7.49e-05	0.00174	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.47e-05	0.00174	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.45e-05	0.00173	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	7.44e-05	0.00173	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	7.44e-05	0.00173	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	7.43e-05	0.00173	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	7.4e-05	0.00172	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	7.4e-05	0.00172	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.3e-05	0.0017	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	7.27e-05	0.00169	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	7.26e-05	0.00169	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	7.15e-05	0.00166	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.1e-05	0.00165	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	7.03e-05	0.00163	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.94e-05	0.00161	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	6.92e-05	0.00161	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.9e-05	0.0016	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	6.87e-05	0.0016	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	6.8e-05	0.00158	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	6.77e-05	0.00157	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.76e-05	0.00157	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	6.64e-05	0.00154	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	6.64e-05	0.00154	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.56e-05	0.00153	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.56e-05	0.00153	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	6.48e-05	0.00151	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	6.48e-05	0.00151	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	6.43e-05	0.0015	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	6.41e-05	0.00149	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	6.35e-05	0.00148	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.33e-05	0.00147	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.29e-05	0.00146	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	6.21e-05	0.00144	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.19e-05	0.00144	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	6.11e-05	0.00142	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	6.11e-05	0.00142	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	6.07e-05	0.00141	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	6.06e-05	0.00141	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	6.06e-05	0.00141	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	5.95e-05	0.00138	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	5.93e-05	0.00138	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	5.91e-05	0.00138	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.88e-05	0.00137	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.85e-05	0.00136	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.75e-05	0.00134	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.75e-05	0.00134	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.65e-05	0.00131	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.65e-05	0.00131	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	5.59e-05	0.0013	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	5.54e-05	0.00129	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.51e-05	0.00128	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	5.38e-05	0.00125	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	5.35e-05	0.00124	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	5.31e-05	0.00123	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.21e-05	0.00121	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.19e-05	0.00121	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	5.18e-05	0.00121	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.15e-05	0.0012	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.14e-05	0.0012	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.12e-05	0.00119	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	4.94e-05	0.00115	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.88e-05	0.00114	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	4.86e-05	0.00113	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	4.84e-05	0.00113	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.82e-05	0.00112	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	4.8e-05	0.00112	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	4.71e-05	0.00109	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	4.69e-05	0.00109	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	4.44e-05	0.00103	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	4.42e-05	0.00103	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	4.38e-05	0.00102	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	4.34e-05	0.00101	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	4.17e-05	0.00097	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	4.08e-05	0.000948	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	4.05e-05	0.000943	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	4.03e-05	0.000937	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.99e-05	0.000929	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.99e-05	0.000929	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	3.76e-05	0.000875	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.74e-05	0.00087	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.74e-05	0.00087	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	3.74e-05	0.00087	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	3.65e-05	0.00085	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.65e-05	0.000849	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	3.64e-05	0.000846	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	3.57e-05	0.00083	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.55e-05	0.000826	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.43e-05	0.000797	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.41e-05	0.000792	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.4e-05	0.00079	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	3.36e-05	0.000781	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.35e-05	0.000779	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	3.32e-05	0.000772	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	3.28e-05	0.000762	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	3.22e-05	0.00075	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.19e-05	0.000743	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.17e-05	0.000738	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	3.09e-05	0.000719	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	3.09e-05	0.000718	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	3.07e-05	0.000715	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	3.06e-05	0.000712	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.06e-05	0.000711	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.89e-05	0.000672	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.82e-05	0.000656	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.8e-05	0.000652	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.79e-05	0.000649	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.76e-05	0.000641	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.69e-05	0.000626	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.54e-05	0.000592	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.54e-05	0.00059	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.52e-05	0.000585	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.51e-05	0.000585	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.4e-05	0.000558	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.29e-05	0.000534	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.19e-05	0.000509	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.02e-05	0.00047	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.96e-05	0.000456	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.93e-05	0.000449	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.92e-05	0.000447	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.92e-05	0.000446	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.8e-05	0.000419	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.76e-05	0.00041	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.72e-05	0.000401	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.66e-05	0.000387	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.66e-05	0.000386	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.66e-05	0.000386	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.65e-05	0.000384	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.57e-05	0.000366	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	0.000355	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.52e-05	0.000353	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	1.48e-05	0.000345	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.48e-05	0.000345	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.45e-05	0.000337	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.45e-05	0.000337	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.36e-05	0.000317	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.36e-05	0.000317	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.35e-05	0.000314	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.33e-05	0.000309	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.26e-05	0.000292	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.26e-05	0.000292	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000291	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.25e-05	0.00029	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.000289	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.12e-05	0.000261	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.09e-05	0.000254	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.03e-05	0.00024	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000238	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.02e-05	0.000236	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.93e-06	0.000231	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.91e-06	0.000207	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.6e-06	0.0002	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.55e-06	0.000199	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.19e-06	0.000191	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.68e-06	0.000179	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.49e-06	0.000174	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.06e-06	0.000164	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	7e-06	0.000163	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	6.74e-06	0.000157	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.62e-06	0.000107	CbGpPWpGaD
